MERCK SA secures contract for Purchase Of Oral Tepotinib 225Mg Com Rev To Lab Merck Sa For Ulsasi, For The Year 2025

Portugal, July 22 -- Portugal based MERCK SA has secured contract from Unidade Local De Saude Amadora/Sintra, E.P.E. for Purchase Of Oral Tepotinib 225Mg Com Rev To Lab Merck Sa For Ulsasi, For The Year 2025. The value of the contract is worth 11947597 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....